ERBB2 and breast cancer: This contribution has two goals: (1) to investigate and quantify the effects of radiation and trastuzumab longitudinally in vitro, and (2) to test the hypothesis that trastuzumab sensitizes HER2+ breast cancer to radiation therapy in an in vivo model of HER2+ breast cancer.